Status:
COMPLETED
Impact of a Pharmacovigilance Program Led by Advanced Practice Nursing
Lead Sponsor:
Natalia Rodriguez Galan
Conditions:
Adverse Drug Event
Eligibility:
All Genders
Phase:
NA
Brief Summary
HYPOTHESIS An advanced practice nursing intervention in the area of pharmacovigilance performed on patients and professionals improves the identification and reporting of suspected adverse drug reacti...
Detailed Description
PRIMARY OBJETIVES 1\. To assess whether an advanced nursing intervention improves the identification and reporting of suspected ADR. SECONDARY OBJECTIVES 1. To determine if an advanced nursing inte...
Eligibility Criteria
Inclusion
- Patients with pharmacological treatment.
- Patients of both sexes aged between 0 and 100 years.
- Patients admitted to medical or surgical hospitalization units or emergency services for at least 24 hours.
- Patients who have received the information and agreed to participate in the study.
Exclusion
- Patients included in other clinical trials or drug studies at the time of selection.
- Patients with significant cognitive impairment, without adequate family support or primary caregiver.
- Patients and/or caregivers who, once offered to participate in the study, do not give their consent
- Impossibility of communication due to language barriers or other biopsychosocial problems.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
395 Patients enrolled
Trial Details
Trial ID
NCT05402254
Start Date
May 1 2022
End Date
December 30 2022
Last Update
October 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital San Carlos
Madrid, Spain, 28040